Cover image for WHO Model Formulary 2008.
WHO Model Formulary 2008.
Title:
WHO Model Formulary 2008.
Author:
Organization, World Health.
ISBN:
9789240684249
Personal Author:
Physical Description:
1 online resource (645 pages)
Series:
Nonserial Publication
Contents:
WHO MODEL FORMULARY 2008 -- Title Page -- Contents -- Abbreviations -- Introduction -- Changes to the WHO Model List of Essential -- General advice to prescribers -- 1. Anaesthetics -- 1.1 General anaesthetics and oxygen -- 1.2 Local anaesthetics -- 1.3 Preoperative medication and sedation for -- 2. Analgesics, antipyretics, non-steroidal anti-inflammatory -- 2.1 Non-opioids and non-steroidal -- 2.2 Opioid analgesics -- 2.3 Medicines used to treat gout -- 2.4 Disease-modifying agents used in rheumatoid -- 3. Antiallergics and medicines used in anaphylaxis -- 4. Antidotes and other substances used in poisonings -- 4.1 Non-specific -- 4.2 Specific -- 5. Anticonvulsants/antiepileptics -- 6. Anti-infective medicines -- 6.1 Anthelminthics -- 6.1.1 Intestinal anthelminthics -- 6.1.2 Antifilarials -- 6.1.3 Antischistosomals and antitrematode medicine -- 6.2 Antibacterials -- 6.2.1 Beta Lactam medicines -- 6.2.2 Other antibacterials -- 6.2.3 Antileprosy medicines -- 6.2.4 Antituberculosis medicines -- 6.3 Antifungal medicines -- 6.4 Antiviral medicines -- 6.4.1 Antiherpes medicines -- 6.4.2 Antiretrovirals -- Fixed-dose combinations -- 6.4.2.1 Nucleoside/Nucleotide reverse transcriptase inhibitors -- 6.4.2.2 Non-nucleoside reverse transcriptase inhibitors -- 6.4.2.3 Protease inhibitors -- 6.4.3 Other antivirals -- 6.5 Antiprotozoal medicines -- 6.5.1 Antiamoebic and antigiardiasis medicines -- 6.5.2 Antileishmaniasis medicines -- 6.5.3 Antimalarial medicines -- 6.5.3.1 For curative treatment -- 6.5.3.2 For prophylaxis -- 6.5.4 Anti-pneumocystosis and antitoxoplasmosis medicines -- 6.5.5 Antitrypanosomal medicines -- 6.5.5.1 African trypanosomiasis -- 6.5.5.2 American trypanosomiasis -- 7. Antimigraine medicines -- 7.1 For treatment of acute attack -- 7.2 For prophylaxis -- 8. Antineoplastic, immunosuppressives and medicines used.

8.1 Immunosuppressive medicines -- 8.2 Cytotoxic medicines -- 8.3 Hormones and antihormones -- 8.4 Medicines used in palliative care -- 9. Antiparkinsonism medicines -- 10. Medicines affecting the blood -- 10.1 Antianaemia medicines -- 10.2 Medicines affecting coagulation -- 11. Blood products and plasma substitutes -- 11.1 Plasma substitutes -- 11.2 Plasma fractions for specific use -- 12. Cardiovascular medicines -- 12.1 Antianginal medicines -- 12.2 Antiarrhythmic medicines -- 12.3 Antihypertensive medicines -- 12.4 Medicines used in heart failure -- 12.5 Antithrombotic medicines -- 12.6 Lipid-lowering agents -- 13. Dermatological medicines (topical) -- 13.1 Antifungal medicines -- 13.2 Anti-infective medicines -- 13.3 Anti-inflammatory and antipruritic medicines -- 13.4 Astringent medicines -- 13.5 Medicines affecting skin differentiation and -- 13.6 Scabicides and pediculicides -- 14. Diagnostic agents -- 14.1 Ophthalmic medicines -- 14.2 Radiocontrast media -- 15. Disinfectants and antiseptics -- 15.1 Antiseptics -- 15.2 Disinfectants -- 16. Diuretics -- 17. Gastrointestinal medicines -- 17.1 Antacids and other antiulcer medicines -- 17.2 Antiemetic medicines -- 17.3 Anti-inflammatory medicines -- 17.4 Laxatives -- 17.5 Medicines used in diarrhoea -- 17.5.1 Oral rehydration -- 17.5.2 Medicines for diarrhoea in children -- 17.5.3 Antidiarrhoeal (symptomatic) medicines in -- 18. Hormones, other endocrine medicines and contraceptives -- 18.1 Adrenal hormones and synthetic substitutes -- 18.2 Androgens -- 18.3 Contraceptives -- 18.3.1 Oral hormonal contraceptives -- 18.3.2 Injectable hormonal contraceptives -- 18.3.3 Intrauterine devices -- 18.3.4 Barrier methods -- 18.3.5 Implantable contraceptives -- 18.4 Estrogens -- 18.5 Insulins and other antidiabetic agents -- 18.6 Ovulation inducers -- 18.7 Progestogens.

18.8 Thyroid hormones and antithyroid medicines -- 19. Immunologicals -- 19.1 Diagnostic agents -- 19.2 Sera and immunoglobulins -- 19.3 Vaccines -- 20. Muscle relaxants (peripherally-acting) and cholinesterase -- 21. Ophthalmological preparations -- 21.1 Anti-infective agents -- 21.2. Anti-inflammatory agents -- 21.3 Local anaesthetics -- 21.4 Miotics and antiglaucoma medicines -- 21.5 Mydriatics -- 22. Oxytocics and antioxytocics -- 22.1 Oxytocics -- 22.2 Antioxytocics (tocolytics) -- 23. Peritoneal dialysis solution -- 24. Psychotherapeutic medicines -- 24.1 Medicines used in psychotic disorders -- 24.2 Medicines used in mood disorders -- 24.2.1 Medicines used in depressive disorders -- 24.2.2 Medicines used in bipolar disorders -- 24.3 Medicines used in generalized anxiety and -- 24.4 Medicines used for obsessive-compulsive -- 24.5 Medicines used in substance-dependence -- 25. Medicines acting on the respiratory tract -- 25.1 Antiasthmatics and medicines for chronic -- 25.2 Other medicines acting on the respiratory tract -- 26. Solutions correcting water, electrolyte and acid-base -- 26.1 Oral -- 26.2 Parenteral -- 26.3 Miscellaneous -- 27. Vitamins and minerals -- Appendix 1: Interactions -- Appendix 2: Pregnancy -- Appendix 3: Breastfeeding -- Appendix 4: Renal impairment -- Appendix 5: Hepatic impairment -- Index.
Abstract:
Since its first publication in 2002, the WHO Model Formulary has become an indispensable source of independent information on essential medicines for pharmaceutical policy-makers and prescribers worldwide. The Model Formulary is the authoritative guide on how to make effective use of the medicines on the WHO Model List of Essential Medicines, so improving patient safety, and limiting unnecessary medical spending. For each medicine the Model Formulary provides information on use, dosage, adverse effects, contraindications and warnings, supplemented by guidance on selecting the right medicine for a range of conditions. The new edition, WHO Model Formulary 2008, details changes made to the WHO Model List of Essential Medicines in 2007, with updated therapeutic information on existing medicines reflecting new clinical knowledge.
Local Note:
Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2017. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
Electronic Access:
Click to View
Holds: Copies: